Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia A Seelig

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Laboratory|May 25, 2016
Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD)Claudia A Seelig, Oliver Bauer, Hans-Peter Seelig
Clinical Laboratory|May 12, 2020
High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA)Claudia A Seelig, Martin Blüthner, Hans-Peter Seelig
Clinical Laboratory|October 28, 2011
Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infectionH P Seelig, H Appelhans, O Bauer, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Laboratory|May 25, 2016
Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD)Claudia A Seelig, Oliver Bauer, Hans-Peter Seelig
Clinical Laboratory|May 12, 2020
High Sensitivity Detection of Anti-DFS70 Antibodies by Radioimmunoprecipitation Assay (RIPA)Claudia A Seelig, Martin Blüthner, Hans-Peter Seelig
Clinical Laboratory|October 28, 2011
Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infectionH P Seelig, H Appelhans, O Bauer, et al.
Pageof 1